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Concentration dependent carbapenem
exposure alters the plasmid copy number
within nosocomial isolates of Escherichia coli
harboring blaNDM-1: A study from Northeast
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1 Assam University, Silchar, Assam, India
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Background: Expansion of blaNDM-1 and its broad host range
results in the propagation of this resistance determinant within
different incompatibility group of plasmids. It is crucial to under-
stand how bacterial extra chromosomal entity responds in the
pathogen encoding the resistance gene when they are exposed
to carbapenem antibiotics. This study investigates the change in
plasmid copy number of blaNDM-1 under the pressure of different
concentration of carbapenem antibiotics within nosocomial iso-
lates of E. coli from a tertiary referral hospital of northeast India.
Methods & Materials: Clinical isolates of E. coli harboring
blaNDM-1 within three different incompatibility plasmid groups
viz; Inc F, Inc A/C and Inc K were grown under the exposure of
imipenem, meropenem and ertapenem with concentration of 0.5,
1, 2 and 4g/ml for each antibiotic. Plasmid was extracted for each
sample and quantitative real time PCR was carried out to estimate
the relative copy number of blaNDM-1 and fold change was normal-
ized against a housekeeping gene rpsel. Curing of different Inc type
plasmidwas done by treating the isolateswith different concentra-
tions of curing agents viz. sodium dodecyl sulfate, acridine orange
and ethidium bromide.
Results: It was observed that the copy number of blaNDM-1 gene
within Inc F and Inc A/C type of plasmids was consistently higher
as the concentration of imipenem and meropenem was increased
whereas in case of ertapenem it was vice versa. In Inc K type
of plasmid, the copy number of blaNDM-1 was consistently raised
only under the exposure of meropenem while with imipenem
and ertapenem, the copy number got reduced. Plasmids encoding
blaNDM-1 could be successfully eliminated after single treatment
with SDS and is considered as the most efﬁcient curing agent. The
curedmutantsbecamesusceptible to carbapenems,quinolonesand
to aminoglycosides antibiotics.
Conclusion: The study could establish that different car-
bapenem concentrations can alter the plasmid copy number
irrespective of their incompatibility types. Also, it underscores sta-
bility of different incompatible plasmids when exposed to a curing
agent. Thus, the current investigation is helpful in predicting the
vertical transmission dynamics of resistance determinants, which
will be key for infection control and slowing down expansion of
multidrug resistance in hospital settings.
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Surveillance of bloodstream infection and
antibiotic resistance in Phnom Penh, Cambodia
(2007–2014)
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L. Leng1, C. Kham1, J. Jacobs2
1 Sihanouk Hospital Center of HOPE, Phnom Penh,
Cambodia
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Background: Bloodstream infections (BSI) cause important
morbidity andmortalityworldwide. In Cambodia, there are limited
data on pathogens causing BSI and their antimicrobial resistance.
We describe the cumulative results of a prospective blood culture
surveillance study in an adults’ hospital in Phnom Penh, Cambodia
between July 2007 and December 2014.
Methods & Materials: Blood cultures (2×10ml) were per-
formed in adults presenting with systemic inﬂammatory response
syndrome (SIRS) at SihanoukHospital CentreofHOPE, PhnomPenh,
Cambodia. Isolates were identiﬁed using standard microbiological
techniques; antibiotic susceptibilities were assessed using disk dif-
fusionandMicroScan,withadditional E-test,D-test anddoubledisk
test, according to CLSI guidelines.
Results: A total of 16,815 pairs of blood-bottle samples from
12,092 patients yielded 1,467 clinically signiﬁcant organisms (CSO,
8.8%). Among them, 1160 (n=79.1%) were Gram-negative bacte-
ria, comprising Escherichia coli (n =436; 29.7%), Salmonella (n =291,
20.0%); Burkholderia pseudomallei (n =133, 9.0%) and Klebsiella spp.
(n =98; 6.7%). Among E. coli, we noted combined resistance to
amoxicillin, trimethoprim-sulfamethoxazole and ciproﬂoxacin in
256 (58.7%) isolates; 59.0% (190/322) isolates testedwere extended
spectrumbeta-lactamase (ESBL) producers, resistance to third gen-
eration cephalosporins increased from 50.0% in 2008 to 73.2% in
2014). In 2 patients, carbapenem-resistant Klebsiella pneumoniae
was isolated. For Burkholderia pseudomallei, no resistance towards
the drugs of use (i.e. ceftazidime, trimethoprim-sulfamethoxazole,
amoxicillin-clavulanic acid)was observed.Wenoted an emergence
of Salmonella Paratyphi A since mid-2012 which was still ongo-
ing at the end of the study period. For Salmonella Typhi (and other
Salmonella serotypes), there was a trend of increasing frequency of
reduced susceptibility to ciproﬂoxacin; ESBL was observed in 2 out
of 18 Salmonella Choleraesuis isolates.
AmongGram-positive CSO, Staphylococcus aureus (n =121, 8.2%)
was predominant; methicillin resistance was observed in 32/121
(26.4%) of S. aureus isolates and increased over time (15.4% versus
36.4% for the years 2008 versus 2014 respectively).
